These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8817641)

  • 41. Inhibition of nitric oxide does not affect reperfusion-induced myocardial injury, but it prevents lipid peroxidation in the isolated rat heart.
    Yang BC; Mehta JL
    Life Sci; 1997; 61(3):229-36. PubMed ID: 9217282
    [TBL] [Abstract][Full Text] [Related]  

  • 42. L-NAME enhances microcirculatory congestion and cardiomyocyte apoptosis during myocardial ischemia-reperfusion in rats.
    Liu P; Xu B; Forman LJ; Carsia R; Hock CE
    Shock; 2002 Mar; 17(3):185-92. PubMed ID: 11900336
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Involvement of superoxide and nitric oxide in the genesis of reperfusion arrhythmias in rats.
    Ohoi I; Takeo S
    Eur J Pharmacol; 1996 Jun; 306(1-3):123-31. PubMed ID: 8813624
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Apoptosis, coronary arterial remodeling, and myocardial infarction after nitric oxide inhibition in SHR.
    Ono Y; Ono H; Matsuoka H; Fujimori T; Frohlich ED
    Hypertension; 1999 Oct; 34(4 Pt 1):609-16. PubMed ID: 10523335
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Real-time monitoring of nitric oxide and blood flow during ischemia-reperfusion in the rat testis.
    Kono T; Saito M; Kinoshita Y; Satoh I; Shinbori C; Satoh K
    Mol Cell Biochem; 2006 Jun; 286(1-2):139-45. PubMed ID: 16496212
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of inducible nitric oxide synthase ameliorates myocardial ischemia/reperfusion injury - induced acute renal injury.
    Chen TH; Liao FT; Yang YC; Wang JJ
    Transplant Proc; 2014 May; 46(4):1123-6. PubMed ID: 24815143
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preconditioning of rat heart with monophosphoryl lipid A: a role for nitric oxide.
    Tosaki A; Maulik N; Elliott GT; Blasig IE; Engelman RM; Das DK
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1274-9. PubMed ID: 9618433
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vivo coronary effects of endothelin-1 after ischemia-reperfusion. Role of nitric oxide and prostanoids.
    Fernández N; Martínez MA; Climent B; García-Villalón AL; Monge L; Sanz E; Diéguez G
    Eur J Pharmacol; 2003 Nov; 481(1):109-17. PubMed ID: 14637182
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
    Liu YN; Zhou ZM; Chen P
    Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):211-6. PubMed ID: 17941891
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential sensitivity of proximal and distal coronary arteries to a nitric oxide donor following reperfusion injury or inhibition of nitric oxide synthesis.
    Coughlan MG; Kenny D; Kampine JP; Bosnjak ZJ; Warltier DC
    Cardiovasc Res; 1993 Aug; 27(8):1444-8. PubMed ID: 8221797
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The dual effects of nitric oxide synthase inhibitors on ischemia-reperfusion injury in rat hearts.
    Kobara M; Tatsumi T; Takeda M; Mano A; Yamanaka S; Shiraishi J; Keira N; Matoba S; Asayama J; Nakagawa M
    Basic Res Cardiol; 2003 Sep; 98(5):319-28. PubMed ID: 12955405
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardioprotective effect of L-arginine in myocardial ischemia and reperfusion in an isolated working rat heart model.
    Izhar U; Schwalb H; Borman JB; Merin G
    J Cardiovasc Surg (Torino); 1998 Jun; 39(3):321-9. PubMed ID: 9678555
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endogenous nitric oxide (NO) protects against ischaemia-reperfusion injury in the rabbit.
    Williams MW; Taft CS; Ramnauth S; Zhao ZQ; Vinten-Johansen J
    Cardiovasc Res; 1995 Jul; 30(1):79-86. PubMed ID: 7553727
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Changes in gastric HCO-3 secretory response to NG-nitro-L-arginine methyl ester in rats following repeated administration.
    Takeuchi K; Takehara K; Kato S; Asada Y; Yasuhiro T
    J Gastroenterol Hepatol; 1996 Dec; 11(12):1164-70. PubMed ID: 9034937
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term treatment with N(omega)-nitro-L-arginine methyl ester causes arteriosclerotic coronary lesions in endothelial nitric oxide synthase-deficient mice.
    Suda O; Tsutsui M; Morishita T; Tanimoto A; Horiuchi M; Tasaki H; Huang PL; Sasaguri Y; Yanagihara N; Nakashima Y
    Circulation; 2002 Sep; 106(13):1729-35. PubMed ID: 12270870
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protection against myocardial ischaemia/reperfusion injury by PPAR-alpha activation is related to production of nitric oxide and endothelin-1.
    Bulhak AA; Sjöquist PO; Xu CB; Edvinsson L; Pernow J
    Basic Res Cardiol; 2006 May; 101(3):244-52. PubMed ID: 16411023
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nitric oxide regulation of TP receptor-mediated pulmonary vasoconstriction in the anesthetized, open-chest rat.
    Valentin JP; Bessac AM; Maffre M; John GW
    Eur J Pharmacol; 1996 Dec; 317(2-3):335-42. PubMed ID: 8997619
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of prostaglandins and nitric oxide on the renal effects of angiotensin II in the anaesthetized rat.
    Clayton JS; Clark KL; Johns EJ; Drew GM
    Br J Pharmacol; 1998 Aug; 124(7):1467-74. PubMed ID: 9723960
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The protective effects of CP-060S on ischaemia- and reperfusion- induced arrhythmias in anaesthetized rats.
    Koga T; Fukazawa M; Suzuki Y; Akima M; Adachi Y; Tamura K; Kato T; Kuromaru O
    Br J Pharmacol; 1998 Apr; 123(7):1409-17. PubMed ID: 9579737
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coronary reactivity to endothelin-1 during partial ischemia and reperfusion in anesthetized goats. Role of nitric oxide and prostanoids.
    Fernández N; Martínez MA; Climent B; García-Villalón AL; Monge L; Sanz E; Diéguez G
    Eur J Pharmacol; 2002 Dec; 457(2-3):161-8. PubMed ID: 12464362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.